After Hours
The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours.
Stocks Info
Olema Pharmaceuticals Inc is listed on the NASDAQ as a member of the Healthcare sector and is a part of the Biotechnology industry. The current market capitalization of Olema Pharmaceuticals Inc is $375.84M. A total of 1.07 million shares were traded on the day, compared to an average of 915.30K shares.
In the most recent transaction, Bain Capital Life Sciences Inv bought 300,000 shares of OLMA for 5.76 per share on Jan 08 ’25. After the transaction, the 10% Owner now owns 7,800,000 company shares. In a previous transaction on Dec 17 ’24, Graham G. Walmsley sold 700,761 shares at 6.75 per share. OLMA shares that Director owns now total 0.
Among the insiders who bought shares, Logos Opportunities Fund I LP acquired of 700,761 shares on Dec 13 ’24 at a per-share price of $6.75. In another insider transaction, Harmon Cyrus sold 8,256 shares at $9.37 per share on Dec 10 ’24. Company shares held by the Director now total 772,277.
Though price targets are rarely accurate, they can exert some influence from time to time and were often accepted as valuable by the market. In terms of 52-week highs and lows, OLMA has a high of $16.77 and a low of $4.60.
As of this writing, OLMA has an earnings estimate of $0.17 per share for the current quarter. EPS was calculated based on a consensus of 6.0 estimates, with a high estimate of $4.23 per share and a lower estimate of -$0.7.
Balance Sheet Annually/Quarterly
A balance sheet is a report that shows the company’s assets and liabilities. In addition, it shows how much equity investors have invested in the company. Investors can determine the company’s prospects by calculating its financial ratios based on this information. OLMA’s latest balance sheet shows that the firm has $287.25M in Cash & Short Term Investments as of fiscal 2021. There were $3.29M in debt and $9.02M in liabilities at the time. Its Book Value Per Share was $3.47, while its Total Shareholder’s Equity was $284.57M.
Analysts Opinion
It may be riskier to trade before market opening and after market closing than during regular market hours. Since issuers often announce critical financial information outside regular trading hours. Extended-hours trading may result in wider spreads for particular securities due to lower liquidity and higher volatility. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for OLMA is Buy with a score of 5.00.
